共 50 条
- [37] EndoPredict-based treatment decision can reduce chemotherapy usage in ER+, HER2-breast cancer [J]. BREAST, 2015, 24 : S107 - S107
- [39] MRI Patterns in the evaluation of pathological response after Neoadjuvant Endocrine therapy in ER+/HER2-Breast Cancer and Implications on Surgical Planning [J]. BREAST, 2023, 68 : S57 - S58